Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'INVASIVE FUNGAL-INFECTIONS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 82 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Arikan, S; Rex, JH
      Lipid-based antifungal agents: Current status

      CURRENT PHARMACEUTICAL DESIGN
    2. Ascioglu, S; De Pauw, BE; Donnelly, JP; Collette, L
      Reliability of clinical research on invasive fungal infections: a systematic review of the literature

      MEDICAL MYCOLOGY
    3. Knoppert, DC; Salama, HEM; Lee, DSC
      Eradication of severe neonatal systemic candidiasis with amphotericin B lipid complex

      ANNALS OF PHARMACOTHERAPY
    4. Quilitz, RE; Arnold, AD; Briones, GR; Dix, SP; Ippoliti, C; Kennedy, LD; Lucich, JL; Mehta, J; Peters, BG; Tice, DS
      Practice guidelines for lipid-based amphotericin B in stem cell transplantrecipients

      ANNALS OF PHARMACOTHERAPY
    5. Snydman, DR
      Posttransplant microbiological surveillance

      CLINICAL INFECTIOUS DISEASES
    6. Hann, IM; Prentice, HG
      Lipid-based amphotericin B: a review of the last 10 years of use

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    7. Giamarellou, H; Antoniadou, A
      Infectious complications of febrile leukopenia

      INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    8. Leather, HL; Wingard, JR
      Infections following hematopoietic stem cell transplantation

      INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    9. Simon, DM; Levin, S
      Infectious complications of solid organ transplantations

      INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    10. Dominguez, EA; Smith, PW
      Empiric antifungal therapy for the neutropenic patient - The Wingard/Leather article reviewed

      ONCOLOGY-NEW YORK
    11. Tomee, JFC; van der Werf, TS
      Pulmonary aspergillosis

      NETHERLANDS JOURNAL OF MEDICINE
    12. Cannon, JP; Garey, KW; Danziger, LH
      A prospective and retrospective analysis of the nephrotoxicity and efficacy of lipid-based amphotericin B formulations

      PHARMACOTHERAPY
    13. Andres, E; Tiphine, M; Letscher-Bru, V; Herbrecht, R
      Review of new lipid formulations of amphotericin B

      REVUE DE MEDECINE INTERNE
    14. Singhal, S; Ellis, RW; Jones, SG; Miller, SJ; Fisher, NC; Hastings, JGM; Mutimer, DJ
      Targeted prophylaxis with amphotericin B lipid complex in liver transplantation

      LIVER TRANSPLANTATION
    15. Patel, R
      Prophylactic fluconazole in liver transplant recipients: A randomized, double-blind, placebo-controlled trial (Reprinted from Ann Intern Med, vol 131, pg 729-737, 1999)

      LIVER TRANSPLANTATION
    16. Richardson, M; Ellis, M
      Clinical and laboratory diagnosis

      HOSPITAL MEDICINE
    17. Graybill, JR; Tollemar, J; Torres-Rodriguez, JM; Walsh, TJ; Roilides, E; Farmaki, E
      Antifungal compounds: controversies, queries and conclusions

      MEDICAL MYCOLOGY
    18. Chiller, TM; Stevens, DA
      Treatment strategies for Aspergillus infections

      DRUG RESISTANCE UPDATES
    19. Fanos, V; Cataldi, L
      Amphotericin B-induced nephrotoxicity: A review

      JOURNAL OF CHEMOTHERAPY
    20. Wingard, JR; White, MH; Anaissie, E; Raffalli, J; Goodman, J; Arrieta, A
      A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia

      CLINICAL INFECTIOUS DISEASES
    21. Singh, N
      Antifungal prophylaxis for solid organ transplant recipients: Seeking clarity amidst controversy

      CLINICAL INFECTIOUS DISEASES
    22. Dismukes, WE
      Introduction to antifungal drugs

      CLINICAL INFECTIOUS DISEASES
    23. Rex, JH; Walsh, TJ; Sobel, JD; Filler, SG; Pappas, PG; Dismukes, WE; Edwards, JE
      Practice guidelines for the treatment of candidiasis

      CLINICAL INFECTIOUS DISEASES
    24. Blau, IW; Fauser, AA
      Review of comparative studies between conventional and liposomal amphotericin B (Ambisome (R)) in neutropenic patients with fever of unknown origin and patients with systemic mycosis

      MYCOSES
    25. De Pauw, BE
      New antifungal agents and preparations

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    26. Kontoyiannis, DP; Luna, MA; Samuels, BI; Bodey, GP
      Hepatosplenic candidiasis - A manifestation of chronic disseminated candidiasis

      INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    27. Bohme, A; Hoelzer, D
      Primary antifungal prophylaxis with low-dose intravenous amphotericin B inhematological malignancies. Results of a pilot study

      ONKOLOGIE
    28. Johnson, EM; Oakley, KL; Radford, SA; Moore, CB; Warn, P; Warnock, DW; Denning, DW
      Lack of correlation of in vitro amphotericin B susceptibility testing withoutcome in a murine model of Aspergillus infection

      Journal of antimicrobial chemotherapy
    29. Garcia, A; Adler-Moore, JP; Proffitt, RT
      Single-dose AmBisome (liposomal amphotericin B) as prophylaxis for murine systemic candidiasis and histoplasmosis

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    30. Santangelo, R; Paderu, P; Delmas, G; Chen, ZW; Mannino, R; Zarif, L; Perlin, DS
      Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    31. Van Etten, EWM; Stearne-Cullen, LET; Ten Kate, MT; Bakker-Woudenberg, IAJM
      Efficacy of liposomal amphotericin B with prolonged circulation in blood in treatment of severe pulmonary aspergillosis in leukopenic rats

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    32. Reyes, E; Cardona, J; Prieto, A; Bernstein, ED; Rodriguez-Zapata, M; Pontes, MJ; Alvarez-Mon, M
      Liposomal amphotericin B and amphotericin B-deoxycholate show different immunoregulatory effects on human peripheral blood mononuclear cells

      JOURNAL OF INFECTIOUS DISEASES
    33. Montejo, M; Valdivielso, A; Suarez, MJ; Testillano, M; Bustamante, J; Gastaca, M; Campo, M; Errazti, G; Perdigo, K; Aguirrebengoa, K; de Zarate, PG; de Urbina, JO
      Infection after orthotopic liver transplantation: analysis of the first 120 consecutive cases

      REVISTA CLINICA ESPANOLA
    34. Bekersky, I; Fielding, RM; Buell, D; Lawrence, I
      Lipid-based amphotericin B formulations: from animals to man

      PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY
    35. Chisholm, J; Devine, T; Mycroft, J; Pinkerton, CR
      Liposomal amphotericin B (AmBisome) in children with febrile neutropenia and renal dysfunction

      INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY
    36. Wingard, JR; Kubilis, P; Lee, L; Yee, G; White, M; Walshe, L; Bowden, R; Anaissie, E; Hiemenz, J; Lister, J
      Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis

      CLINICAL INFECTIOUS DISEASES
    37. Sheehan, DJ; Hitchcock, CA; Sibley, CM
      Current and emerging azole antifungal agents

      CLINICAL MICROBIOLOGY REVIEWS
    38. Muller, FMC; Groll, AH; Walsh, TJ
      Current approaches to diagnosis and treatment of fungal infections in children infected with human immune deficiency virus

      EUROPEAN JOURNAL OF PEDIATRICS
    39. Andriole, VT
      Current and future antifungal therapy: new targets for antifungal agents

      Journal of antimicrobial chemotherapy
    40. Robinson, RF; Nahata, MC
      A comparative review of conventional and lipid formulations of amphotericin B

      JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    41. Le Gouill, S; Morineau, N; Miegeville, M; Milpied, N; Harousseau, JL; Moreau, P
      Pseudallescheria boydii arthritis in a patient with acute lymphoblastic leukemia: A case report.

      REVUE DE MEDECINE INTERNE
    42. Hay, RJ
      Lipid amphotericin B combinations; "la creme de la creme'?

      JOURNAL OF INFECTION
    43. Richter, S; Cormican, MG; Pfaller, MA; Lee, CK; Gingrich, R; Rinaldi, MG; Sutton, DA
      Fatal disseminated Trichoderma longibrachiatum infection in an adult bone marrow transplant patient: Species identification and review of the literature

      JOURNAL OF CLINICAL MICROBIOLOGY
    44. Denning, DW; Warn, P
      Dose range evaluation of liposomal nystatin and comparisons with amphotericin B and amphotericin B lipid complex in temporarily neutropenic mice infected with an isolate of Aspergillus fumigatus with reduced susceptibility to amphotericin B

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    45. Walsh, TJ; Finberg, RW; Arndt, C; Hiemenz, J; Schwartz, C; Bodensteiner, D; Pappas, P; Seibel, N; Greenberg, RN; Dummer, S; Schuster, M; Holcenberg, JS
      Liposomal amphotericin B for empirical therapy in patients with persistentfever and neutropenia

      NEW ENGLAND JOURNAL OF MEDICINE
    46. Pascual, MJ; Vaquero, M
      Fever, abdominal pain and coma in a 48-year-old patient with acute promyelocytic leukemia during neutropenia following chemotherapy

      MEDICINA CLINICA
    47. Bohme, A; Karthaus, M; Hoelzer, D
      Antifungal prophylaxis in neutropenic patients with hematologic malignancies: Is there a real benefit?

      CHEMOTHERAPY
    48. Gurwith, M
      Clinical efficacy of amphotericin B colloidal dispersion against infections caused by Aspergillus spp

      CHEMOTHERAPY
    49. SINGH RM; PERDUE BE
      AMPHOTERICIN-B - A CLASS REVIEW

      Formulary
    50. WONGBERINGER A; JACOBS RA; GUGLIELMO BJ
      LIPID FORMULATIONS OF AMPHOTERICIN-B - CLINICAL EFFICACY AND TOXICITIES

      Clinical infectious diseases
    51. KAUFFMAN CA; WISEMAN SW
      ANAPHYLAXIS UPON SWITCHING LIPID-CONTAINING AMPHOTERICIN-B FORMULATIONS

      Clinical infectious diseases
    52. NOSKIN GA; PIETRELLI L; COFFEY G; GURWITH M; LIANG LJ
      AMPHOTERICIN-B COLLOIDAL DISPERSION FOR TREATMENT OF CANDIDEMIA IN IMMUNOCOMPROMISED PATIENTS

      Clinical infectious diseases
    53. WALSH TJ; HIEMENZ J
      LIPID FORMULATIONS OF AMPHOTERICIN-B - RECENT DEVELOPMENTS IN IMPROVING THE THERAPEUTIC INDEX OF A GOLD STANDARD

      Infectious diseases in clinical practice
    54. Hiemenz, JW; Walsh, TJ
      Lipid formulations of amphotericin B

      JOURNAL OF LIPOSOME RESEARCH
    55. JOHNSON MD; DREW RH; PERFECT JR
      CHEST DISCOMFORT ASSOCIATED WITH LIPOSOMAL AMPHOTERICIN-B - REPORT OF3 CASES AND REVIEW OF THE LITERATURE

      Pharmacotherapy
    56. GULATI M; BAJAD S; SINGH S; FERDOUS AJ; SINGH M
      DEVELOPMENT OF LIPOSOMAL AMPHOTERICIN-B FORMULATION

      Journal of microencapsulation
    57. WALSH TJ; YELDANDI V; MCEVOY M; GONZALEZ C; CHANOCK S; FREIFELD A; SEIBEL NI; WHITCOMB PO; JAROSINSKI P; BOSWELL G; BEKERSKY I; ALAK A; BUELL D; BARRET J; WILSON W
      SAFETY, TOLERANCE, AND PHARMACOKINETICS OF A SMALL UNILAMELLAR LIPOSOMAL FORMULATION OF AMPHOTERICIN-B (AMBISOME) IN NEUTROPENIC PATIENTS

      Antimicrobial agents and chemotherapy
    58. Presterl, E; Graninger, W
      Trends in the treatment of systemic mycoses

      WIENER KLINISCHE WOCHENSCHRIFT
    59. Patel, R
      Antifungal agents. Part I. Amphotericin B preparations and flucytosine

      MAYO CLINIC PROCEEDINGS
    60. CLARK AD; MCKENDRICK S; TANSEY PJ; FRANKLIN IM; CHOPRA R
      A COMPARATIVE-ANALYSIS OF LIPID-COMPLEXED AND LIPOSOMAL AMPHOTERICIN-B PREPARATIONS IN HEMATOLOGICAL ONCOLOGY

      British Journal of Haematology
    61. RICHARDSON MD; KOKKI MH
      ANTIFUNGAL THERAPY IN BONE-MARROW FAILURE

      British Journal of Haematology
    62. Tweddle, DA; Graham, JC; Shankland, GS; Kernahan, J
      Cerebral candidiasis in a child 1 year after leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    63. ALABDELY H; REVANKAR S; GRAYBILL JR
      LIPID FORMULATIONS OF AMPHOTERICIN-B

      Seminars in respiratory and critical care medicine
    64. GONZALEZ CE; COURIEL DR; WALSH TJ
      DISSEMINATED ZYGOMYCOSIS IN A NEUTROPENIC PATIENT - SUCCESSFUL TREATMENT WITH AMPHOTERICIN-B LIPID COMPLEX AND GRANULOCYTE-COLONY-STIMULATING FACTOR

      Clinical infectious diseases
    65. REVANKAR SG; PATTERSON TF
      ASPERGILLUS AND CANDIDA INFECTIONS IN BONE-MARROW TRANSPLANTATION - PROGRESS AND CONTROVERSIES

      Infectious diseases in clinical practice
    66. GOTZSCHE PC; JOHANSEN HK
      METAANALYSIS OF PROPHYLACTIC OR EMPIRICAL ANTIFUNGAL TREATMENT VERSUSPLACEBO OR NO TREATMENT IN PATIENTS WITH CANCER COMPLICATED BY NEUTROPENIA

      BMJ. British medical journal
    67. MANFREDI R; CORONADO OV; MASTROIANNI A; CHIODO F
      LIPOSOMAL AMPHOTERICIN-B AND RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGECOLONY-STIMULATING FACTOR (RHUGM-CSF) IN THE TREATMENT OF PEDIATRIC AIDS-RELATED CRYPTOCOCCOSIS

      International journal of STD & AIDS
    68. POYNTON CH
      IMMUNE MODULATION BY CYTOKINES IN THE TREATMENT OF OPPORTUNISTIC INFECTIONS

      Current opinion in infectious diseases
    69. RUHNKE M; BEYER J
      ANTIMYCOTIC PROPHYLAXIS IN NEUTROPENIC AN D IMMUNOSUPPRESSED PATIENTS

      Medizinische Klinik
    70. TOREN A; OR R; ACKERSTEIN A; NAGLER A
      INVASIVE FUNGAL-INFECTIONS IN LYMPHOMA PATIENTS RECEIVING IMMUNOTHERAPY FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)

      Bone marrow transplantation
    71. HILLERY AM
      SUPRAMOLECULAR LIPIDIC DRUG-DELIVERY SYSTEMS - FROM LABORATORY TO CLINIC - A REVIEW OF THE RECENTLY INTRODUCED COMMERCIAL LIPOSOMAL AND LIPID-BASED FORMULATIONS OF AMPHOTERICIN-B

      Advanced drug delivery reviews
    72. MYLONAKIS E; CHALEVELAKIS G; SAROGLOU G; DANIAS P; ARGYROPOULOU AD; PANIARA O; RAPTIS SA
      EFFICACY OF DEOXYCHOLATE AMPHOTERICIN-B AND UNILAMELLAR LIPOSOMAL AMPHOTERICIN-B IN PROPHYLAXIS OF EXPERIMENTAL ASPERGILLUS-FUMIGATUS ENDOCARDITIS

      Mayo Clinic proceedings
    73. RICHARDSON MD
      LIPID COMPLEXES OF AMPHOTERICIN-B - THE COMPETITIVE PICTURE

      Journal of Medical Microbiology
    74. KAUFFMAN CA; CARVER PL
      ANTIFUNGAL AGENTS IN THE 1990S - CURRENT STATUS AND FUTURE-DEVELOPMENTS

      Drugs
    75. HERBRECHT R
      REVIEW OF LIPID-AMPHOTERICIN-B FORMULATIONS IN THE TREATMENT OF CANDIDIASIS AND PERSONAL-EXPERIENCE

      Journal de mycologie medicale
    76. HIEMENZ JW; WALSH TJ
      LIPID FORMULATIONS OF AMPHOTERICIN-B - RECENT PROGRESS AND FUTURE-DIRECTIONS

      Clinical infectious diseases
    77. ANDSTROM EE; RINGDEN O; REMBERGER M; SVAHN BM; TOLLEMAR J
      SAFETY AND EFFICACY OF LIPOSOMAL AMPHOTERICIN-B IN ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS

      Mycoses
    78. HERBRECHT R
      THE CHANGING EPIDEMIOLOGY OF FUNGAL-INFECTIONS - ARE THE LIPID-BASED FORMS OF AMPHOTERICIN-B AN ADVANCE

      European journal of haematology
    79. CHANOCK SJ; PIZZO PA
      FEVER IN THE NEUTROPENIC HOST

      Infectious disease clinics of North America
    80. LUMBRERAS C; CUERVASMONS V; JARA P; DELPALACIO A; TURRION VS; BARRIOS C; MORENO E; NORIEGA AR; PAYA CV
      RANDOMIZED TRIAL OF FLUCONAZOLE VERSUS NYSTATIN FOR THE PROPHYLAXIS OF CANDIDA INFECTION FOLLOWING LIVER-TRANSPLANTATION

      The Journal of infectious diseases
    81. KLINGSPOR L; EBERHARD TH; STINTZING G; TOLLEMAR J
      ANTIBODY-RESPONSE TO CANDIDA AND ITS USE IN CLINICAL-PRACTICE

      Mycoses
    82. RINGDEN O
      CLINICAL USE OF AMBISOME(R) WITH SPECIAL EMPHASIS ON EXPERIENCE IN CHILDREN

      Bone marrow transplantation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/08/20 alle ore 19:12:38